Conferences - Results from #9480

ASCO 2013 - Poster: Open-label, multicenter study of sipuleucel-T in men with metastatic castrate resistant prostate cancer (mCRPC) previously treated with sipuleucel-T: Evaluation of antigen presenting cell (APC) activation and ELISPOT data June 3, 2013

ASCO 2013 - Poster: Safety of radium-223 dichloride with docetaxel in patients with bone metastases from castration-resistant prostate cancer (CRPC): A phase I Prostate Cancer Clinical Trials Consortium study June 3, 2013

ASCO 2013 - Poster: Safety of radium-223 dichloride with docetaxel in patients with bone metastases from castration-resistant prostate cancer (CRPC): A phase I Prostate Cancer Clinical Trials Consortium study June 3, 2013

ASCO 2013 - Poster: Prospective evaluation of testosterone (T) recovery and PSA relapse following 18 months of androgen deprivation (ADT) after prostatectomy (RP): Results from the Tax-3501 trial June 3, 2013

ASCO 2013 - Poster: Prospective evaluation of testosterone (T) recovery and PSA relapse following 18 months of androgen deprivation (ADT) after prostatectomy (RP): Results from the Tax-3501 trial June 3, 2013

ASCO 2013 - Poster: An exploratory analysis of bone scan lesion area, circulating tumor cell change, pain reduction, and overall survival in patients with castration-resistant prostate cancer treated with cabozantinib June 3, 2013

ASCO 2013 - Poster: An exploratory analysis of bone scan lesion area, circulating tumor cell change, pain reduction, and overall survival in patients with castration-resistant prostate cancer treated with cabozantinib June 3, 2013

ASCO 2013 - Podcast: Open-label, multicenter study of sipuleucel-T in men with metastatic castrate resistant prostate cancer (mCRPC) previously treated with sipuleucel-T: Evaluation of antigen presenting cell (APC) activation and ELISPOT data June 3, 2013

ASCO 2013 - Podcast: Evolving patterns of metastatic disease in castration-resistant prostate cancer (CRPC) reported in clinical trials from 1990 to 2011 June 3, 2013

ASCO 2013 - Podcast: Prospective evaluation of testosterone (T) recovery and PSA relapse following 18 months of androgen deprivation (ADT) after prostatectomy (RP): Results from the TAX-3501 trial June 3, 2013

ASCO 2013 - Podcast: Prospective evaluation of testosterone (T) recovery and PSA relapse following 18 months of androgen deprivation (ADT) after prostatectomy (RP): Results from the TAX-3501 trial June 3, 2013

ASCO 2013 - Podcast: The genomic relationship among matched prostate cancer foci June 3, 2013

ASCO 2013 - Podcast: The genomic relationship among matched prostate cancer foci June 3, 2013

ASCO 2013 - Podcast: Evidence for a field effect in early prostate cancer (PCa): Gene expression profiles in normal-appearing prostate tissue (NT) adjacent to tumor (T) as predictors of clinical outcome June 3, 2013

ASCO 2013 - Podcast: Evidence for a field effect in early prostate cancer (PCa): Gene expression profiles in normal-appearing prostate tissue (NT) adjacent to tumor (T) as predictors of clinical outcome June 3, 2013

ASCO 2013 - Podcast: Long-term safety and efficacy analysis of abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer without prior chemotherapy (COU-AA-302) June 1, 2013

ASCO 2013 - Slide Lecture: Relationship of baseline PSA and degree of PSA decline to radiographic progression-free survival in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: Results from COU-AA-302 June 1, 2013

ASCO 2013 - Poster: Long-term safety and efficacy analysis of abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer without prior chemotherapy (COU-AA-302) June 1, 2013

ASCO 2013 - Poster: Relationship of baseline PSA and degree of PSA decline to radiographic progression-free survival in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: Results from COU-AA-302 June 1, 2013

ASCO 2013 - Slide Presentation: Relationship of baseline PSA and degree of PSA decline to radiographic progression-free survival in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: Results from COU-AA-302 June 1, 2013

Page 475 of 507